Faculty, Residents and Fellows contribute abstracts accepted for presentation at 2017 Annual Meeting on Women’s Cancer®
Congratulations to West Cancer Center’s Gynecologic Oncology Division, who successfully submitted seven abstracts for acceptance at the SGO’s Annual Meeting on Women’s Cancer, March 12-15, 2017 in National Harbor, MD.
Since 1969, women’s health care professionals have convened at the Society of Gynecologic Oncology (SGO)’s Annual Meeting on Women’s Cancer® to discuss the latest science in the field, receive educational programming, and to network. The 48th SGO Annual Meeting in 2017 will continue to be the premier educational and scientific event for those who treat and care for women with gynecologic cancer.
Abstracts accepted for presentation from West Cancer Center Faculty, Residents and Fellows include:
Oral Presentation: Focused Plenary II: Surgery
M. Ulm, C. Watson, A.ElNaggar, T. Tillmanns. A randomized controlled trial comparing the efficacy of perioperative celecoxib versus ketorolac for perioperative pain control
A.ElNaggar, M. Ulm, P. Blackburn, T. Tillmanns, M. Reed. Close vulvar cancer margins are not strongly associated with recurrence or survival
A.ElNaggar, M. Ulm, T. Tillmanns. Neo-adjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort
C.Watson, A.ElNaggar, T.Tillmanns, M.Ulm. Recurrence in obese patients with stage I endometrioid endometrial cancer: Does para-aortic lymph node dissection matter?
C.Coffman, A. ElNaggar, T. Tillmanns. Radiofrequency ablation for the treatment of recurrent gynecological malignancies: A case series
A. ElNaggar. Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a national cancer institute-designated comprehensive cancer center
L. Daily, M. Ulm, A.ElNaggar, T.Tillmanns. Postoperative opioids: Are physicians prescribing more than what is necessary for adequate pain control?